BMEA BIOMEA FUSION INC revenue, earnings and financials
For the quarter ended June 30, 2026, BIOMEA FUSION INC reported revenue of n/a, net income of −$8.33M and diluted EPS of −$0.12; for the fiscal year ended December 2025 revenue was n/a.
BMEA annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$83.5M, net income −$61.8M (margin n/a), EPS −$1.18
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$144M, net income −$138M (margin n/a), EPS −$3.83
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$126M, net income −$117M (margin n/a), EPS −$3.44
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$83.6M, net income −$81.8M (margin n/a), EPS −$2.80
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$41.7M, net income −$41.6M (margin n/a), EPS −$1.74
BMEA quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$8.33M, EPS −$0.12
- Quarter ended Mar 31, 2026: revenue n/a, net income −$12.4M, EPS −$0.17
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income $4.61M, EPS $0.40
- Quarter ended Sep 30, 2025: revenue n/a, net income −$16.4M, EPS −$0.27
- Quarter ended Jun 30, 2025: revenue n/a, net income −$20.7M, EPS −$0.51
- Quarter ended Mar 31, 2025: revenue n/a, net income −$29.3M, EPS −$0.80
- Quarter ended Dec 31, 2024: revenue n/a, net income −$29.3M, EPS −$0.81
- Quarter ended Sep 30, 2024: revenue n/a, net income −$32.8M, EPS −$0.91
- Quarter ended Jun 30, 2024: revenue n/a, net income −$37.3M, EPS −$1.03
- Quarter ended Mar 31, 2024: revenue n/a, net income −$39.1M, EPS −$1.09
- Quarter ended Dec 31, 2023: revenue n/a, net income −$34.9M, EPS −$0.98
- Quarter ended Sep 30, 2023: revenue n/a, net income −$28.4M, EPS −$0.80
- Quarter ended Jun 30, 2023: revenue n/a, net income −$24.9M, EPS −$0.70
- Quarter ended Mar 31, 2023: revenue n/a, net income −$29.1M, EPS −$0.98
- Quarter ended Dec 31, 2022: revenue n/a, net income −$25.3M, EPS −$0.86
- Quarter ended Sep 30, 2022: revenue n/a, net income −$22.9M, EPS −$0.78
- Quarter ended Jun 30, 2022: revenue n/a, net income −$17.3M, EPS −$0.59
- Quarter ended Mar 31, 2022: revenue $1.07B (up 0.0% year over year), net income −$16.4M, EPS −$0.56
- Quarter ended Dec 31, 2021: revenue n/a, net income −$14.7M, EPS −$0.51
- Quarter ended Sep 30, 2021: revenue n/a, net income −$12.6M, EPS −$0.43
BMEA cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$70.4M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$120M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$96.6M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$62.4M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$35.4M, share buybacks n/a
BMEA balance sheet
- Jun 30, 2026: cash $34.8M, total assets $36.9M, total liabilities $24.7M, shareholders' equity $12.1M
- Mar 31, 2026: cash $44.7M, total assets $46.4M, total liabilities $27.7M, shareholders' equity $18.7M
- Dec 31, 2025: cash $55.8M, total assets $58.6M, total liabilities $29.0M, shareholders' equity $29.6M
- Sep 30, 2025: cash $46.6M, total assets $55.2M, total liabilities $39.6M, shareholders' equity $15.6M
- Jun 30, 2025: cash $56.2M, total assets $73.2M, total liabilities $45.7M, shareholders' equity $27.5M
- Mar 31, 2025: cash $35.9M, total assets $55.1M, total liabilities $26.3M, shareholders' equity $28.7M
- Dec 31, 2024: cash $58.3M, total assets $79.9M, total liabilities $28.4M, shareholders' equity $51.6M
- Sep 30, 2024: cash $88.0M, total assets $110M, total liabilities $34.4M, shareholders' equity $76.0M
Is BMEA profitable?
No. BIOMEA FUSION INC lost $32.5M over the last four quarters.
What is BMEA's EPS?
Diluted earnings per share over the last four quarters were −$0.16; −$0.12 in the latest quarter.